<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04541004</url>
  </required_header>
  <id_info>
    <org_study_id>MT-18</org_study_id>
    <secondary_id>2020-000446-34</secondary_id>
    <nct_id>NCT04541004</nct_id>
  </id_info>
  <brief_title>Adolescent Mite Allergy Safety Evaluation</brief_title>
  <acronym>AMASE</acronym>
  <official_title>A 28-day, Single-armed, Open-label Trial to Evaluate Safety of the House Dust Mite (HDM) Sublingual Allergy Immunotherapy (SLIT) Tablet in Adolescent Subjects With HDM Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ALK-Abelló A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Syneos Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>ALK-Abelló A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a 28-day clinical trial studying the safety of the house dust mite tablet in&#xD;
      adolescents with allergic rhinitis/rhinoconjunctivitis.&#xD;
&#xD;
      The purpose of this trial is to collect additional safety information about a tablet used to&#xD;
      treat house dust mite allergies, when used to treat adolescents who have these allergies.&#xD;
&#xD;
      The trial medication used is already approved to treat allergic rhinitis caused by house dust&#xD;
      mite in adults and adolescents (12-17 years old) in several countries.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This trial is a 28-day, single-arm open-label phase III trial to evaluate safety of the house&#xD;
      dust mite SLIT-tablet in adolescents (12-17 years of age) with HDM allergic&#xD;
      rhinitis/rhinoconjunctivitis with or without asthma. Approximately 250 adolescents will be&#xD;
      enrolled in the trial and will receive the house dust mite SLIT tablet. The trial is&#xD;
      conducted in several European countries.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 23, 2020</start_date>
  <completion_date type="Actual">April 24, 2021</completion_date>
  <primary_completion_date type="Actual">April 24, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>single-armed</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Non applicable</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment-emergent adverse event (TEAE)</measure>
    <time_frame>From time of first IMP administration and no later than 7 days after last IMP administration, approximately 35 days.</time_frame>
    <description>Number and proportion of subjects with at least one TEAE, as well as number of events.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Solicited TEAE</measure>
    <time_frame>From time of first IMP administration and no later than 7 days after last IMP administration, approximately 35 days.</time_frame>
    <description>Number and proportion of subjects with at least one solicited TEAE, as well as number of events.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IMP-related AE</measure>
    <time_frame>From time of first IMP administration and no later than 7 days after last IMP administration, approximately 35 days.</time_frame>
    <description>Number and proportion of subjects with at least one IMP-related AE, as well as number of events.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment-emergent serious adverse events (SAE)</measure>
    <time_frame>From time of first IMP administration and no later than 7 days after last IMP administration, approximately 35 days.</time_frame>
    <description>Number and proportion of subjects with at least one treatment-emergent SAE, as well as number of events.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">254</enrollment>
  <condition>Allergic Rhinitis</condition>
  <condition>Allergic Rhinoconjunctivitis</condition>
  <arm_group>
    <arm_group_label>HDM SLIT Tablet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>House dust mite (HDM) Sublingual allergy immunotherapy tablet</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>HDM SLIT-tablet</intervention_name>
    <description>Sublingual allergy immunotherapy tablet, for daily administration (1 tablet per day)</description>
    <arm_group_label>HDM SLIT Tablet</arm_group_label>
    <other_name>ACARIZAX, ODACTRA</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
          -  Male or female subjects aged ≥12 to ≤17 years&#xD;
&#xD;
          -  A clinical history of allergic rhinitis/rhinoconjunctivitis (AR/C) when exposed to HDM&#xD;
&#xD;
          -  Positive skin prick test (SPT) to Dermatophagoides pteronyssinus and/or&#xD;
             Dermatophagoides farinae at screening&#xD;
&#xD;
          -  Lung function measured by Forced expiratory volume in 1 second (FEV1) ≥ 70% of&#xD;
             predicted value or according to local requirements while on subject's usual asthma&#xD;
             medication&#xD;
&#xD;
          -  The subject must be willing and able to comply with trial protocol and adhere to IMP&#xD;
             treatment&#xD;
&#xD;
        Main Exclusion Criteria:&#xD;
&#xD;
          -  A subject who has previously been included in studies with the HDM SLIT-tablet, or&#xD;
             otherwise being treated with the marketed HDM SLIT-tablet (e.g. ACARIZAX, ODACTRA)&#xD;
&#xD;
          -  Any SLIT or SCIT treatment with D. pteronyssinus or D. farinae reaching the&#xD;
             maintenance dose within the last 5 years. In addition, any SLIT or SCIT treatment with&#xD;
             D. pteronyssinus or D. farinae within the previous 12 months prior to visit 1&#xD;
&#xD;
          -  Ongoing treatment with any allergy immunotherapy product at screening&#xD;
&#xD;
          -  Severe chronic oral inflammation&#xD;
&#xD;
          -  A diagnosis or history of eosinophilic oesophagitis&#xD;
&#xD;
          -  Any clinical deterioration of asthma that resulted in emergency treatment,&#xD;
             hospitalisation or treatment with systemic corticosteroids within 3 months prior to&#xD;
             first tablet administration&#xD;
&#xD;
          -  Female with positive urine pregnancy test, breastfeeding, pregnant or planning to&#xD;
             become pregnant within the projected duration of the trial&#xD;
&#xD;
          -  Sexually active female of childbearing potential without medically accepted&#xD;
             contraceptive method&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Horn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HNO Praxis am Neckar</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alergopraktik s.r.o.</name>
      <address>
        <city>Jablonec Nad Nisou</city>
        <zip>46601</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allergology Jihlava</name>
      <address>
        <city>Jihlava</city>
        <zip>58601</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oblastni nemocnice Kolin, a.s. Detske oddeleni. Alergologicka a</name>
      <address>
        <city>Kolín</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alergologicka ordinace</name>
      <address>
        <city>Kutná Hora</city>
        <zip>28401</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alergomyšl s.r.o.</name>
      <address>
        <city>Litomyšl</city>
        <zip>57014</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alergologie SKOPKOVA s.r.o.</name>
      <address>
        <city>Ostrava</city>
        <zip>70900</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KASMED s.r.o.</name>
      <address>
        <city>Tábor</city>
        <zip>39002</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alergologicka ambulance</name>
      <address>
        <city>Čáslav</city>
        <zip>28601</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HNO Praxis am Neckar</name>
      <address>
        <city>Heidelberg</city>
        <state>Baden-Wrttemberg</state>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dres. med. Florian Heimlich und Angelika Witzel-Heimlich</name>
      <address>
        <city>Heidelberg</city>
        <state>Baden-Wuerttemberg</state>
        <zip>69126</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Decot</name>
      <address>
        <city>Dreieich</city>
        <state>Hessen</state>
        <zip>63303</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinderarztpraxis BramscheDr. Thomas Adelt</name>
      <address>
        <city>Bramsche</city>
        <state>Niedersachsen</state>
        <zip>49565</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HNO-Genossenschaft Sachsen-Anhalt E.G.</name>
      <address>
        <city>Wolmirstedt</city>
        <state>Sachsen-Anhalt</state>
        <zip>39326</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HNO-Praxis Dr. med. Udo Schaefer</name>
      <address>
        <city>Dresden</city>
        <state>Sachsen</state>
        <zip>01067</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Facharzt fr HNO und Allergologie</name>
      <address>
        <city>Dresden</city>
        <state>Saxony</state>
        <zip>013999</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ambulancia klinickej imunologie a alergologie</name>
      <address>
        <city>Banská Bystrica</city>
        <zip>97405</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALIAN s.r.o.</name>
      <address>
        <city>Bardejov</city>
        <zip>08501</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jocia s.r.o.</name>
      <address>
        <city>Bratislava</city>
        <zip>82108</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AlergoImuno centrum s.r.o. - Ambulancia alergologi</name>
      <address>
        <city>Kezmarok</city>
        <zip>06001</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALERGO H2B s.r.o. Ambulancia klinickej imunológie a alergológie</name>
      <address>
        <city>Komárno</city>
        <zip>94501</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alersa</name>
      <address>
        <city>Košice</city>
        <zip>04022</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ambulancie klinickej imunologie a alergologie Univerzitna nemocnica Martin</name>
      <address>
        <city>Martin</city>
        <zip>03659</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZZ Imunologicka ambulancia</name>
      <address>
        <city>Poprad</city>
        <zip>05801</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alergo immunological center prešov</name>
      <address>
        <city>Prešov</city>
        <zip>08001</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diagnosticke centrum - Ambulancia klinickej imunologie a alergologie, Zoll-Med, s.r.o.</name>
      <address>
        <city>Rimavská Sobota</city>
        <zip>901981</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medimun s.r.o.</name>
      <address>
        <city>Trnava</city>
        <zip>91701</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ambulancia klinickej imunologie a alergologie, NZZ Ambulancia klinickej imunologie</name>
      <address>
        <city>Šurany</city>
        <zip>94201</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
    <country>Germany</country>
    <country>Slovakia</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>September 1, 2020</study_first_submitted>
  <study_first_submitted_qc>September 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 9, 2020</study_first_posted>
  <last_update_submitted>July 16, 2021</last_update_submitted>
  <last_update_submitted_qc>July 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Allergic rhinitis</keyword>
  <keyword>House dust mite</keyword>
  <keyword>Adolescent</keyword>
  <keyword>Pediatric</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Rhinitis, Allergic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

